SAM #36C25722D0064

Sole Source Modification for Additional Referral Lab Testing Services at North Texas Veterans Health Care

This notice announces a sole-source contract modification by the Department of Veterans Affairs, Network Contracting Office 17, for additional referral laboratory testing services at the North Texas Veterans Health Care System in Dallas, TX. - Sole-source, out-of-scope modification to an existing IDIQ Firm-Fixed-Price contract with Mayo Collaborative Services, LLC - Purpose: Add specialized referral laboratory tests for the Pathology and Laboratory Department - Location: 4500 South Lancaster Road, Dallas, TX - Services include: - UBA1 Mutation Quant (CPT 81403, 4 tests annually) - Prothrombin G20210A Mutation, Blood (CPT 81240-F2, 4 tests annually) - TP53 Mutation, NGS (CPT 88381, 81351, 5 tests annually) - Chronic Lymphocytic Leukemia FISH Diagnostics (CPT 88271x12, 88275x6, 88291, 4 tests annually) - PKLR Full Gene Analysis (CPT 81405, 4 tests annually) - B-cell Lymphoma NGS (CPT 81450, 4 tests annually) - UDP-Glucuronosyltransferase 1A1 (UGT1A1) (CPT 81404, 4 tests annually) - Copper, Liver Tissue (CPT 82525, 5 tests annually) - CNS Demyelinating Disease Evaluation, Serum (CPT 86053, 86363, 3 tests annually) - Justification: Sole source under 41 U.S.C. 1901 and FAR 6.103-1(c); not open for competitive proposals, but capability statements from other vendors may be considered for future needs - Estimated annual test volumes are low (3-5 per test type) - No specific period of performance stated; modification applies to annual test volumes

Description

The Government intends to negotiate and award a sole-source, out-of-scope modification to an existing IDIQ Firm-Fixed-Price (FFP) contract currently held by Mayo Collaborative Services, LLC. This modification will add additional referral Lab Testing to the North Texas Veterans Health Care, 4500 South Lancaster Road, Dallas, TX 75216 Pathology and Laboratory Department. Additional lab testing added as follows:

Item Number Test Name CPT Codes Estimated Annual Test Volume 3032 4032 UBA1Mutation Quant 81403 4 3033 4033 Prothrobmin G20210A Mutation, Blood 81240-F2 4 3034 4034 TP53 Mutation, NGS 88381, 81351 5 3035 4035 Chronic Lymphocytic Leukemia FISH Diagnostics 88271x12, 88275x6, 88291 4 3036 4036 PKLR Full gene analysis 81405 4 3037 4037 B-cell lymphoma NGS 81450 4 3038 4038 UDP-Glucuronosyltransferase 1A1 (UGT1A1) 81404 4 3039 4039 Copper, Liver Tissue 82525 5 3040 4040 CNS Demyelinating Disease Evaluation, Serum 86053,86363 3

The statutory authority permitting this sole source acquisition is 41 U.S.C. 1901 as implemented by RFO FAR 6.103-1 (c ). Acquisitions conducted under simplified acquisition procedures are exempt from the requirements in FAR Part 6. A copy of the justification will made publicly available within 14 days of modification execution in accordance with RFO FAR 6.301. This notice of intent is NOT a request for competitive proposals. However, all responsible sources may submit a capability statement which shall be considered by the agency. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement in the future. A determination by the Government not to compete this proposed action based upon responses to this notice is solely within the discretion of the Government

View original listing